News
4 Health Supplement Brands Using Science-Backed Ingredients
Most supplement shoppers don't realize how wide the gap is between brands that actually back their formulas with research and brands that just use convincing packaging. Health supplement brands operating in today's market face real pressure: FDA DSHEA guidelines...
News
Best AI Healthcare Software Development Companies in 2026
Not every company that builds software for healthcare builds AI for healthcare. The distinction matters. Rule-based alert systems, workflow portals, and EHR modules are healthcare software. Predictive models, NLP-driven documentation, and computer vision for clinical imaging are healthcare AI....
Business & Industry
Bayer and Iambic Collaboration Expands AI Drug Discovery Efforts
Bayer has strengthened its pharmaceutical and ophthalmology portfolio through two separate transactions, completing the acquisition of Perfuse Therapeutics while also entering a collaboration agreement with Iambic Therapeutics. The moves provide Bayer with full ownership of Perfuse’s lead asset, PER-001,...
Clinical Trials
US Clinical Trials Plan Aims to Restore Research Leadership
The US Department of Health and Human Services (HHS) has outlined a new strategy aimed at reinforcing the country’s position in pharmaceutical research as competition from China intensifies. Through an initiative called Operation Trailblazer, HHS plans to introduce measures...
Business & Industry
Lilly and BioArctic Partner on BrainTransporter Technology
Eli Lilly and Company has entered into a research and collaboration agreement with Swedish biopharmaceutical company BioArctic to advance a potential treatment for neurodegenerative diseases. Under the arrangement, the companies will combine BioArctic’s BrainTransporter Technology with an undisclosed Lilly...
Business & Industry
AbbVie Acquires Apogee in $10.9 Billion Healthcare Deal
In a significant expansion of its research and development capabilities, a definitive agreement has been reached where AbbVie acquires Apogee Therapeutics for $10.9 billion. This strategic transaction is centered around the addition of zumilokibart, a highly anticipated IL-13 antibody,...
News
The Growing Challenge of Patient Non-Compliance in Modern Healthcare
Advances in medical research, pharmaceutical innovation, and healthcare technology have significantly improved the ability of healthcare providers to diagnose, treat, and manage a wide range of conditions. Despite these advancements, one persistent challenge continues to impact patient outcomes across...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read